Amyotrophic Lateral Sclerosis

September 30, 2022

The price of a new ALS treatment is $158,000 per year, the manufacturer says

[ad_1] The therapy’s list price, Relyvrio, is much higher than recommended by an economic research group, but the company says most patients will pay very little themselves. [ad_2] Source link
September 29, 2022

FDA approves ALS treatment despite questions about efficacy

[ad_1] The drug is safe, and one study found it may prolong survival and slow paralysis in functions like muscle control and speech. A larger trial will be completed in 2024. [ad_2] Source link
September 29, 2022

FDA approves ALS treatment despite questions about efficacy

[ad_1] The drug is safe, and one study found it may prolong survival and slow paralysis in functions like muscle control and speech. A larger trial will be completed in 2024. [ad_2] Source link
FDA approves ALS treatment despite questions about efficacy
This website uses cookies to improve your experience. By using this website you agree to our Data Protection Policy.
Read more